Allelic deletions of at least three discrete regions of the short arm of chromosome 3 have been found in diverse human cancers and may indicate the sites of novel tumour-suppressor genes (Brauch et al. 1987 : Naylor et al. 1987 : Zbar et al. 1987 : Lisitsyn et al. 1994 : Zeiger et al. 1994 : Kastury et al. 1996 . One such site is at 3pl4.2. a location that was first highlighted by a reciprocal chromosomal translocation. t(3:8)(pl4.2:q24). in a family with hereditary renal cell carcinoma (RCC: Cohen et al. 1979) . This site also coincides with the most common aphidicolin-inducible fragile site in humans. FRA3B (Paradee et al. 1995) . Recently. a novel gene. FHIT (fragile histidine triad) . that maps to chromosome 3pl4.2 has been implicated as the target of these abnormalities . The human MHIT protein has dinucleoside 5'.5"'-PI.P -triphosphate (Ap A) hydrolase activity and belongs to a family of proteins that are highly conserved in evolution. The precise cellular function of these proteins is unclear but they may be involved in the regulation of DNA replication and signalling stress responses (Bames et al. 1996) . The FHIT locus consists of ten exons distributed over at least 500 kb and is transcribed as a 1.1 kbnmRNA (Figure l:Ohtaetal. 1996 ).
Absence of FHIT mRNA has been reported in some head and neck squamous cell carcinoma (HNSCC) and oesophageal cell lines (Mao et al. 1996 : Zou et al. 1997 . but bv far the most commonly reported FHIT abnormalities in primary tumour samples are the presence of small aberrant transcripts that lack to o or more exons. Such apparent aberrations have been found using reverse transcription polymerase chain reaction (RT-PCR) in a large proportion of cases of oesophageal and Gastrointestinal tumours . small-cell and non-small-cell lung carcinomas (Sozzi et al. 1996a) . HNSCC (Mao et al. 1996 : Virgailio et al. 1996 . Merkel cell carcinomas (Sozzi et al. 1996b ) and breast carcinomas (Neggrini et al. 1996 . However. no small transcripts were detected in colorectal tumours (Thiagalingam et al. 1996) .
As FHIT is widely expressed. it may also be involved in the pathogenesis of other malignancies. The aim of this studv was to determine whether abnormalities of this gene are found in acute leukaemia. including blast crisis of chronic mveloid leukaemia.
MATERIALS AND METHODS Patient and control samples
Expression of the FHIT gene was evaluated in 119 peripheral blood (PB) or bone marrow (BM) samples obtained from a total of 97 individuals with leukaemia and 16 normal healthy volunteers. Leukaemia samples were from patients with chronic mveloid leukaemia in blast crisis (CML-BC. n = 51). acute mveloid leukaemia (AML. n = 15). acute lymphoblastic leukaemia (ALL. n = 8). unclassified acute leukaemia (n = 3) and CML in chronic phase (CML-CP. n = 26). For six individuals with CML. both chronic phase and blast crisis samples were analysed. All acute leukaemia and CML-BC samples contained at least 75%7 blast cells: all CML-CP samples were derived from patients with 100% Philadelphia chromosome-positive bone marrow metaphases.
For loss of heterozygosity (LOH) analysis. a total of 44 paired DNA samples from patients with CML were investigated. DNA from patients in blast crisis was compared with chronic-phase DNA (n = 28). buccal epithelial cell DNA (n = 12) or both (n = 4). RT-PCR Mononuclear cells v ere isolated using density gradient centrifugation. and total cellular RNA was prepared by lysis in guanidine thiocyanate and caesium chloride ultracentrifugation as described (Sambrook et al. 1989) . Two to ten micrograms of total RNA (equivalent to approximately 10-cells) was used for first-strand cDNA synthesis using random hexamer primers. The integrity of all cDNAs was verified by single-step amplification of the normal ABL aene as described (Cross et al. 1993 ). To test for normal and abnormal MHIT transcripts. a two-step nested PCR was used to amplify the entire coding region using primers (5U2. 5Ul. 3D2 and 3DI) and conditions essentially identical to those described previously .
Sequencing
FHIT PCR products were gel purified and directly sequenced in both orientations by thermal cyclingz with fluorescent dye terminators using primers FHIT-F (5'-TACATCCAGACGGTGGA-3') and FHIT-R (5'-GGTCT1CAAACTGGTTG-3'). which were internal to the second-step primers SU1 and 3D1. Figure 3 ). Fusion products were detected with the following exons spliced together: exons 3-7 (n = 6). exons 3-8 (n = 1). exons 3-9 (n = 1). exons 4-8 (n = 1). exons 6-8 (n = 1). exons 4-7 (n = 3) and exons 4-9 (n = 1).
LOH analysis
Expected-size PCR products of 241 bp for D3S 1300 and 104 bp for D3S1481 were amplified in all cases tested. Of the 44 paired samples amplified for D3S 1300. 29 (66%7) were informative. For D3S1481. 21 (78%) of the 27 cases tested were informative. Overall. 36 (82%) of the 44 paired samples were informative for at least one of the loci. LOH w as not detected in any of the informative cases at either locus.
SSCP
SSCP analysis was performed for 67 samples (CML-BC. n = 45: CML-CP. n =3: AML. n = 14: ALL. n =2: AL. n = 3). In addition to the 1 -bp deletion in the 3' untranslated region (L7UTR) described above. band shifts for one fragment were noted for four samples (6%c). Sequence analysis revealed two previously reported silent polymorphisms: a C to T change at codon 88 (alanine. GCC -GCT) and a T to C change at codon 98 (histidine. CAT -* CAC) (Mao et al. 1996 : Thiagalingam et al. 1996 : Yanagisawa et al. 1996 . No other changes were found.
DISCUSSION
CML is a clonal myeloproliferative disorder that usually presents in chronic phase but eventually progresses to an acute leukaemia (blast crisis) in almost all patients. Although the BCR-ABL fusion gene can be detected in 90-95%c of cases and plays a central role in the pathogenesis of chronic phase CML (Melo. 1996) . little is known about the molecular events responsible for the transformation from chronic phase to blast crisis (Sill et al. 1995) . Similarly. a complete description of the molecular pathogenesis of de noVo acute leukaemia is lacking.
Allelic deletions at 3p14.2 ha e been reported in a wide variety of solid tumours and also in chronic lymphocytic leukaemia (Negnrni et al. 1996 : Sozzi et al. 1996b : Virgilio et al. 1996 : Fong et al. 1997 : Hayashi et al. 1997 : Hendricks et al. 1997 : Luan et al. 1997 Importantly, however, these apparently aberrant transcripts were also found in normal lymphocytes. indicating that they are not specific to malignant cells. Indeed. small products were found in a greater proportion of normal individuals than in patients with leukaemia. suggestingy that they may be more common in lymphocytes or more mature mveloid cells than in immature blasts. Small FHIT PCR products were not only seen after nested RT-PCR but were also detectable by Southern analysis of single-step amplification reactions. indicating that they are not simply derived from very rare transcripts that were selectively amplified by nested PCR. In all cases. the relative intensity of the small PCR products was weak compared with that derived from the intact transcript. but was similar to that seen in many solid tumours : Sozzi et al. 1996a and b: Havashi et al. 1997 . In these studies. it was suggested that the weak intensity of the small bands may have arisen because of the presence of an excess of contaminating normal cells. Our data. and those of others (van den Berg et al. 1997 : Bugert et al. 1997 : Panagopoulos et al. 1997 . suggest that small FHIT transcripts probably arise from a low frequency of altermative splicing in both normal and malignant cells.
Most studies to date have reported the presence of small FHIT transcripts that lack exon 8. at least in some cases. This exon encodes the histidine triad. which is essential for the catalytic activity of the enzyme (Barnes et al. 1996) . Many of the products that we sequenced from both normal individuals and patients with leukaemia contained exon 8. but most lacked exon 5. This exon contains the FHIT initiation codon and. as there is no upstream in frame ATG. mRN'As lacking exon 5 are unlikely to encode a func- 
